SCHEMBL23309574

SCHEMBL23309574

Cc1cnc(NC(=O)c2cc(F)nc(F)c2F)s1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ RAB9A P51151 13/20 0.50
▸ NPC1 O15118 12/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ SMN1; SMN2 Q16637 7/20 0.49
▸ LMNA P02545 3/20 0.48
▸ PKM P14618 3/20 0.48
▸ MITF O75030 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ POLB P06746 3/20 0.46
▸ HPGD P15428 2/20 0.45
▸ PAX8 Q06710 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ AHR P35869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309488 0.77 CYP1A2 (0.52) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL10253187 0.75 ALDH1A1 (0.66) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL23309587 0.73 MAPT (0.47) ALDH1A1MEN1KMT2AKDM4EPOLB
SCHEMBL23309621 0.72 RAB9A (0.50) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL23309614 0.72 LCK (0.45) ALDH1A1SMN1; SMN2LMNAPKMMAPT
SCHEMBL23309730 0.72 KMT2A (0.47) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL23309725 0.72 GAA (0.43) ALDH1A1HPGD
SCHEMBL23309505 0.72 ALDH1A1 (0.43) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL23309594 0.71 POLB (0.50) ALDH1A1NPC1KMT2AKDM4EMAPK1
SCHEMBL24072351 0.71 RAB9A (0.65) ALDH1A1RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL ALDH1A1 2033/4885RAB9A 286/4885NPC1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback